According to the WHO, inequalities in access to health services explain the observed differences in life expectancy. The COVID-19 crisis exposed this reality, from inequalities in access to vaccines to the difficulties faced by health systems…
According to the WHO, inequalities in access to health services explain the observed differences in life expectancy. The COVID-19 crisis exposed this reality, from inequalities in access to vaccines to the difficulties that health systems have had to function effectively. What are the reasons behind these differences in access to healthcare?
First of all, there is a Geographical reason. It is estimated that, worldwide, 646 million people – 8% of the world’s population – do not have access to a medical center less than an hour from their home. This situation, if possible, is more dramatic when we consider that some pathologies require constant medical monitoring. Among the solutions identified are telemedicine and related technologies, which respond to so-called medical deserts and provide rapid care to isolated people.
second, there is a commercial purpose. For example, in the US, 33% of the adult population cannot afford to continue prescribed treatment or seek counseling for economic reasons. Faced with this alarming reality, companies must innovate to improve the affordability of health care and gambling.
The third reason is the lack of availability of personnel and treatment., Europe will face a shortage of one million workers in the health sector. This shortage of medical personnel undermines the ability to care for the sick. The challenge of availability also affects treatment. 300 million people worldwide suffer from a disease that currently has no cure. Companies must mobilize to respond to this dual challenge by, for example, developing software that allows doctors to be more efficient, as well as innovative biopharmaceuticals for diseases that are not covered, such as rare diseases or certain cancers. .
Finally, lack of confidence, The final challenge identified relates to the acceptance of treatments and the trust citizens place in their health system to provide them with the best possible treatment. Mistrust is directly related to various factors, such as concerns about the quality of medical services due to scandals exposed in the media, or the painful nature of certain treatments. Improving patients’ confidence in the quality of care is also a source of innovation for companies, particularly those developing innovative medical devices such as wireless insulin pumps, which contribute to greater comfort and adoption of treatments.
Finally, these are the four dimensions that correspond to the main challenges of access to healthcare as defined by WHO and that the LFDE intends to cover thanks to its methodology. In short, challenges that must be addressed, but also opportunities for investment.